Valuation Theralase Technologies Inc.

Stocks

Delayed Toronto S.E. 09:33:57 2026-08-21 EDT			5-day change	1st Jan Change
0.1950 ^CAD	+2.63%		+5.41%	+18.18%

08-09	Theralase Technologies Inc. announced that it expects to receive CAD 5 million in funding	CI
05-29	Theralase Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	76.6	69.28	39.98	65.66	43.71	56.18	-	-
Change	-	-9.56%	-42.29%	64.23%	-33.43%	28.52%	-	-
Enterprise Value (EV)	76.6	69.28	39.98	65.66	43.71	56.18	56.18	56.18
Change	-	-9.56%	-42.29%	64.23%	-33.43%	28.52%	0%	0%
P/E	-17x	-12.8x	-7.95x	-14.7x	-10.3x	-19x	9.5x	2.71x
PBR	15.1x	21.5x	17.5x	31.9x	23.5x	9.5x	4.75x	1.73x
PEG	-	-0.9x	0.7x	0.8x	0.9x	0.5x	-0x	0x
Capitalization / Revenue	98.1x	60.8x	37.4x	63.5x	53.5x	70x	1.66x	0.75x
EV / Revenue	0x	0x	0x	0x	0x	70x	1.66x	0.75x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.022	-0.025	-0.022	-0.018	-0.016	-0.01	0.02	0.07
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	0.7806	1.139	1.07	1.033	0.8165	0.802	33.89	74.69
EBITDA	-	-	-	-	-	-	-	-
EBIT	-	-	-	-	-	-	-	-
Net income ¹	-4.411	-5.235	-4.571	-4.256	-4.121	-4.2	6.831	20.04
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	0.3750	0.3200	0.1750	0.2650	0.1650	0.1900	0.1900	0.1900
Nbr of stocks (in thousands)	204,276	216,503	228,461	247,780	264,909	295,671	-	-
Announcement Date	4/29/22	4/26/23	3/27/24	3/12/25	5/4/26	-	-	-

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
THERALASE TECHNOLOGIES INC.	-19x	-	-	-	40.79M
EL.EN. S.P.A.	20.24x	1.61x	9.93x	1.72%	1.42B
MODULIGHT OYJ	-16x	5.15x	28.32x	-	55.58M
Average	-4.92x	3.38x	19.12x	1.72%	505.17M
Weighted average by Cap.	17.85x	1.74x	10.62x	1.72%